Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.44 |
| ▸ | AR | P10275 | 4/20 | 0.43 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.39 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128771 | 1.00 | ESR1 (0.44) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL6651902 | 0.84 | TRPV4 (0.48) | ARTRPV4UPP1MAOAMAOB | |
| SCHEMBL8811100 | 0.82 | ESR1 (0.42) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL1312049 | 0.80 | ESR1 (0.37) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL30840298 | 0.80 | ESR1 (0.44) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL23835342 | 0.80 | ESR1 (0.44) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL1578639 | 0.79 | AR (0.42) | ESR1ESR2ARPGR | |
| SCHEMBL14920227 | 0.76 | TRPV4 (0.43) | ESR1ESR2ARTRPV4UPP1 | |
| SCHEMBL29987655 | 0.76 | PIM1 (0.41) | ESR1ESR2AR | |
| SCHEMBL1512796 | 0.76 | PIM1 (0.41) | ESR1ESR2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081885-A | Substituted phenyl glycoside compound and preparation method and application thereof | 浙江大学 | 2025-06-03 | — | — | CN | claimed |
| CN-120081885-A | Substituted phenyl glycoside compound and preparation method and application thereof | 浙江大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-114466849-B | N-substituted-3, 4- (fused 5-ring) -5-phenyl-pyrrolidin-2-one compounds as ISOQC and/or inhibitors of QC enzymes | 欣尼克免疫有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-118307534-A | LTA4H inhibitors and uses thereof | 上海海雁医药科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118159530-A | Compounds for the treatment of pain, in particular neuropathic pain and/or other diseases or disorders associated with AT2R and/or AT2R mediated signalling | 康福治疗有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-112424181-B | Substituted condensed thiophenes as STING modulators | 希泰克斯特私人有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-117529476-A | Preparation of substituted 1, 2-diamino heterocyclic derivatives and their use as medicaments | 亚飞络思制药公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-114466849-A | N-substituted-3, 4- (fused 5-ring) -5-phenyl-pyrrolidin-2-one compounds as inhibitors of ISOQC and/or QC enzymes | 欣尼克免疫有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-108218849-B | Novel inhibitors | 维沃永治疗公众有限公司 | 2022-03-01 | — | — | CN | disclosed |